Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial

Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial

<p><strong>Background: </strong>Determining a therapeutic window for maintaining antiretroviral drug concentrations within an appropriate range is required for identifying effective dosing regimens. The limits of this window are typically calculated using predictive models...

书目详细资料
Main Authors:	Schomaker, M, Denti, P, Bienczak, A, Burger, D, Díaz, I, Gibb, DM, Walker, AS, McIlleron, H
格式:	Journal article
语言:	English
出版:	Wiley 2024

相似书籍

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
由: Bienczak, A, et al.
出版: (2016)

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
由: Bienczak, A, et al.
出版: (2016)

Evaluation of an immunoassay for determination of plasma efavirenz concentrations in resource‐limited settings
由: Alemseged Abdissa, et al.
出版: (2014-01-01)

Pharmacokinetics of antiretroviral drugs in infancy
由: Helen McIlleron, et al.
出版: (2009-12-01)

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
由: Bienczak, A, et al.
出版: (2017)

Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.
由: Fillekes, Q, et al.
出版: (2011)

The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children
由: Bienczak, A, et al.
出版: (2016)

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
由: Selemani Saidi Sungi, et al.
出版: (2018-10-01)

Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
由: Larru B, et al.
出版: (2014-05-01)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
由: Mulenga, V, et al.
出版: (2016)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
由: Kekitiinwa, A, et al.
出版: (2017)

Getting drug doses right in children with tuberculosis (TB)
由: H. McIlleron
出版: (2014-04-01)

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
由: Gary Maartens
出版: (2020-01-01)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
由: Musiime, V, et al.
出版: (2014)

Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy
由: Innocent Lule Segamwenge, et al.
出版: (2018-01-01)

Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy
由: Globahan Ajibola, et al.
出版: (2020-01-01)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
由: Vandercam Bernard, et al.
出版: (2010-05-01)

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
由: Oudijk, J, et al.
出版: (2012)

Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
由: Dorward, J, et al.
出版: (2023)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
由: Roeland E. Wasmann, et al.
出版: (2023-04-01)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
由: Chang Huang, et al.
出版: (2023-03-01)

Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.
由: Jan Vesterbacka, et al.
出版: (2013-01-01)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
由: Richard Court, et al.
出版: (2021-04-01)

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.
由: Patience Nyakato, et al.
出版: (2020-01-01)

Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer
由: Marcel A. Schneider, et al.
出版: (2021-11-01)

Efavirenz in pregnancy
由: Polly Clayden, et al.
出版: (2010-11-01)

Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
由: Lufina Tsirizani Galileya, et al.
出版: (2023-11-01)

Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis
由: Lufina Tsirizani Galileya, et al.
出版: (2023-11-01)

Estratégias utilizadas para o incremento da solubilidade do fármaco antiretroviral classe II: Efavirenz
由: Tarcyla Andrade Gomes, et al.
出版: (2015-04-01)

Estratégias utilizadas para o incremento da solubilidade do fármaco antiretroviral classe II: Efavirenz
由: Tarcyla Andrade Gomes, et al.
出版: (2015-10-01)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
由: Adelline Twimukye, et al.
出版: (2021-11-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
由: Sanjeev Sinha, et al.
出版: (2017-12-01)

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans
由: Jenna Johnston, et al.
出版: (2019-04-01)

Efavirenz-induced urolithiasis.
由: Wirth, G, et al.
出版: (2006)

Efavirenz and neuropsychiatric effects
由: Mukesh Dheda
出版: (2017-04-01)

Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study
由: Sinxadi Phumla Z, et al.
出版: (2012-10-01)

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
由: Gabriella Jomara da Silva, et al.
出版: (2023-05-01)

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
由: Rebecca Zash, MD, et al.
出版: (2018-07-01)

Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil
由: T. Vanni, et al.
出版: (2007-07-01)

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
由: Sandra Shawarira-Bote, et al.
出版: (2019-08-01)